» Articles » PMID: 29273867

A New Multi-Mode Perfusion System for Ex Vivo Heart Perfusion Study

Overview
Journal J Med Syst
Date 2017 Dec 24
PMID 29273867
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Ex vivo heart perfusion has been shown to be an effective means of facilitating the resuscitation and assessment of donor hearts for cardiac transplantation. Over the last ten years however, only a few ex vivo perfusion systems have been developed for this application. While results have been promising, a system capable of facilitating multiple perfusion strategies on the same platform has not yet been realized. In this paper, the design, development and testing of a novel and modular ex vivo perfusion system is described. The system is capable of operating in three unique primary modes: the traditional Langendorff Mode, Pump-Supported Working-Mode, and Passive Afterload Working-Mode. In each mode, physiological hemodynamic parameters can be produced by managing perfusion settings. To evaluate heart viability, six experiments were conducted using porcine hearts and measuring several parameters including: pH, aortic pressure, lactate metabolism, coronary vascular resistance (CVR), and myocardial oxygen consumption. Pressure-volume relationship measurements were used to assess left ventricular contractility in each Working Mode. Hemodynamic and metabolic conditions remained stable and consistent across 4 h of ex vivo heart perfusion on the ex vivo perfusion system, validating the system as a viable platform for future development of novel preservation and assessment strategies.

Citing Articles

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment.

Olverson 4th G, Higuita M, Bolger-Chen M, Ajenu E, Li S, Kharroubi H J Vis Exp. 2024; (210).

PMID: 39158286 PMC: 11815639. DOI: 10.3791/66624.


A machine-learning approach to human ex vivo lung perfusion predicts transplantation outcomes and promotes organ utilization.

Sage A, Donahoe L, Shamandy A, Mousavi S, Chao B, Zhou X Nat Commun. 2023; 14(1):4810.

PMID: 37558674 PMC: 10412608. DOI: 10.1038/s41467-023-40468-7.


Echocardiographic assessment of left ventricular function in ex situ heart perfusion using pump-supported and passive afterload working mode: a pilot study.

Hondjeu A, Mashari A, Ramos R, Ruggeri G, Gellner B, Ribeiro R J Anesth Analg Crit Care. 2023; 1(1):20.

PMID: 37386658 PMC: 10246397. DOI: 10.1186/s44158-021-00018-3.


Dynamic Metabolic Changes During Prolonged Heart Perfusion Are Associated With Myocardial Functional Decline.

Olkowicz M, Ribeiro R, Yu F, Alvarez J, Xin L, Yu M Front Immunol. 2022; 13:859506.

PMID: 35812438 PMC: 9267769. DOI: 10.3389/fimmu.2022.859506.


A novel nonlinear afterload for ex vivo heart evaluation: Porcine experimental results.

Pigot H, Soltesz K, Paskevicius A, Liao Q, Sjoberg T, Steen S Artif Organs. 2022; 46(9):1794-1803.

PMID: 35548921 PMC: 9545718. DOI: 10.1111/aor.14307.


References
1.
White C, Ali A, Hasanally D, Xiang B, Li Y, Mundt P . A cardioprotective preservation strategy employing ex vivo heart perfusion facilitates successful transplant of donor hearts after cardiocirculatory death. J Heart Lung Transplant. 2013; 32(7):734-43. DOI: 10.1016/j.healun.2013.04.016. View

2.
Proctor E, Parker R . Preservation of isolated heart for 72 hours. Br Med J. 1968; 4(5626):296-8. PMC: 1912305. DOI: 10.1136/bmj.4.5626.296. View

3.
Trahanas J, Witer L, Alghanem F, Bryner B, Iyengar A, Hirschl J . Achieving 12 Hour Normothermic Ex Situ Heart Perfusion: An Experience of 40 Porcine Hearts. ASAIO J. 2016; 62(4):470-6. PMC: 4925299. DOI: 10.1097/MAT.0000000000000382. View

4.
Van Caenegem O, Beauloye C, Bertrand L, Horman S, Lepropre S, Sparavier G . Hypothermic continuous machine perfusion enables preservation of energy charge and functional recovery of heart grafts in an ex vivo model of donation following circulatory death. Eur J Cardiothorac Surg. 2015; 49(5):1348-53. DOI: 10.1093/ejcts/ezv409. View

5.
Ardehali A, Esmailian F, Deng M, Soltesz E, Hsich E, Naka Y . Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial. Lancet. 2015; 385(9987):2577-84. DOI: 10.1016/S0140-6736(15)60261-6. View